Heart failure trials in Saudi Arabia
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Al Ahsa, Jeddah, Riyadh
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - No phaseTaking peopleTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Where
- Riyadh
- Age
- 18 years and over
- People
- 850 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT06526195 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Jeddah, Riyadh
- People
- 20,000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Jeddah, Riyadh
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Al Ahsa, Dammam, Riyadh
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Dammam, Jeddah, Riyadh
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00